Waters and the University of Warwick, Coventry, UK, have signed a collaborative research agreement that is intended to support the growth, development and adoption of novel mass spectrometry (MS) technologies.

"I believe that this partnership between a proven technology leader and a leading research focused university will provide a platform for the development of many exciting new projects," said Prof James Scrivens, Department of Biological Sciences, University of Warwick.

At the core of the collaborative agreement is the establishment of The Waters Centre for BioMedical Mass Spectrometry at the University of Warwick, a centre of excellence in state-of-the-art MS techniques. The centre is expected to offer scientists worldwide an accessible resource to enable the adoption of cutting edge LC–MS-based techniques in life science.

"The University of Warwick is consistently ranked amongst the top research universities, with an historic track record in biological mass spectrometry," said Brian Smith, vice president of Mass Spectrometry Operations for the Waters Division. "Waters looks forward to taking this relationship to the next level through mutually beneficial research and a world-class educational resource for life scientists adopting cutting edge MS-based research strategies."

More information about the university is available at www.warwick.ac.uk

For more about Waters visit www.waters.com